| Dr Steven Hendler, MD | |
|
11111 Nall Ave, # 222, Leawood, KS 66211-1625 | |
| (913) 338-5448 | |
| (913) 317-8340 |
| Full Name | Dr Steven Hendler |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine & Rehabilitation |
| Location | 11111 Nall Ave, Leawood, Kansas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063462992 | NPI | - | NPPES |
| 404065 | Other | BC BS OF KS | |
| 4662708 | Other | AETNA | |
| 250013267 | Other | KS | RAILROAD MEDICARE PIN |
| 0669109004 | Other | CIGNA | |
| 2196144 | Other | AETNA | |
| 250013268 | Other | KS | RAILROAD MEDICARE PIN |
| 250013266 | Other | MO | RAILROAD MEDICARE PIN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 102443 (Missouri) | Secondary |
| 208100000X | Physical Medicine & Rehabilitation | 04-24433 (Kansas) | Primary |
| Entity Name | Partners In Rehab Medicine |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578968368 PECOS PAC ID: 3678899242 Enrollment ID: O20150226001621 |
News Archive
Cortex Pharmaceuticals, Inc. reported a net loss of approximately $356,000, or $0.00 per share, for the quarter ended June 30, 2011, compared with a net loss of approximately $2,454,000, or $0.04 per share, for the corresponding prior year period, with the difference reflecting revenues in the current year period from the Company's option agreement with Servier, France's largest privately held pharmaceutical company.
While some scientists report engineering a super virulent strain of the H5N1 influenza virus, which could potentially wipe out a significant percentage of the human population, another group of researchers from the United Kingdom now reports a discovery that may one day help mitigate the deadly effects of all flu strains.
A lacquer containing resin from the Norway spruce shows promise as a treatment for onychomycosis, suggest results from an exploratory study.
Micronics, Inc., a medical device development company, today announced that the U.S. Food and Drug Administration has granted the company 510(k) clearance to market its ABORhCard, a qualitative in vitro test that provides a simultaneous determination of an individual's ABO blood group and Rh factor status. It is not for use for blood bank processing of blood products, for determining RHD status for the purpose of administration of Rh immunoglobulin, or for screening purposes prior to transfusion.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Steven Hendler, MD 11111 Nall Ave, #222, Leawood, KS 66211-1625 Ph: (913) 338-5448 | Dr Steven Hendler, MD 11111 Nall Ave, # 222, Leawood, KS 66211-1625 Ph: (913) 338-5448 |
News Archive
Cortex Pharmaceuticals, Inc. reported a net loss of approximately $356,000, or $0.00 per share, for the quarter ended June 30, 2011, compared with a net loss of approximately $2,454,000, or $0.04 per share, for the corresponding prior year period, with the difference reflecting revenues in the current year period from the Company's option agreement with Servier, France's largest privately held pharmaceutical company.
While some scientists report engineering a super virulent strain of the H5N1 influenza virus, which could potentially wipe out a significant percentage of the human population, another group of researchers from the United Kingdom now reports a discovery that may one day help mitigate the deadly effects of all flu strains.
A lacquer containing resin from the Norway spruce shows promise as a treatment for onychomycosis, suggest results from an exploratory study.
Micronics, Inc., a medical device development company, today announced that the U.S. Food and Drug Administration has granted the company 510(k) clearance to market its ABORhCard, a qualitative in vitro test that provides a simultaneous determination of an individual's ABO blood group and Rh factor status. It is not for use for blood bank processing of blood products, for determining RHD status for the purpose of administration of Rh immunoglobulin, or for screening purposes prior to transfusion.
› Verified 7 days ago
Shynda F Miles, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 8800 State Line Rd, Leawood, KS 66206 Phone: 913-383-9099 Fax: 913-213-6026 | |
Sadie Schulze Laughlin, DPT Physical Medicine & Rehabilitation Medicare: May Accept Medicare Assignments Practice Location: 9425 Mission Rd, Leawood, KS 66206 Phone: 913-381-2100 Fax: 913-273-1458 | |
Dr. Stephen Nathan Rosenberg, DO Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 4940 W 137th Street, Suite B, Leawood, KS 66224 Phone: 913-424-9670 Fax: 913-851-4430 | |
Dr. Fermin Jose Santos, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 3651 College Blvd, Leawood, KS 66211 Phone: 913-319-7600 Fax: 913-253-1702 | |
Micheal Thomas Murphy, MD Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 3651 College Blvd, Leawood, KS 66211 Phone: 913-319-7600 Fax: 913-253-1702 | |
Dr. Daniel Byron Sisk, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 3651 College Blvd, Leawood, KS 66211 Phone: 913-319-7600 Fax: 913-253-1702 |